// App-Quantinova.ai

e18505 : Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia.

Researchers

Presenter

  • Carolyn Marie Larsen

Principal Investigators

  • Hector R. Villarraga

  • Kebede Begna

  • Mark Robert Litzow

  • Aref Al-Kali

  • Joerg Herrmann

Medical Centers

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute Coronary Syndromes

  • Acute myelocytic leukemia

  • Congestive heart failure

  • Arrhythmia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Nilotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved